09-Dec-2013 - Hospira says it intends to up in-house manufacture of its APIs from 10 to 50% by 2018 as it awaits completion of last year’s acquisition of Orchid.
News in brief
09-Dec-2013 - B Braun Melsungen AG has changed the type of stoppers used to seal its injectable metabolic acidosis treatment, sodium bicarbonate, after quality problems that resulted in a UK MHRA alert last week.
05-Dec-2013 - Jubilant Life Sciences has received a US FDA warning letter for its manufacturing plant in Spokane, Washington State.
05-Dec-2013 - A lawsuit alleging that the US FDA unlawfully detained a batch of acetaminophen API destined for CMO Gemini Pharmaceuticals could have significant impact on the drug industry's definition of an ‘end user.'
04-Dec-2013 - Ideal Cures has launched a new mobile phone ‘app’ designed to help customers make better use of its range of coating products.
News in brief
03-Dec-2013 - Ingredient supplier ChemCon GmbH has been cleared to make semi-solid dosage forms by German regulators.
02-Dec-2013 - BASF has raises the price of 1,4 Butanediol (BDO) and its derivatives, citing energy costs as a key factor.
27-Nov-2013 - Actavis says it is restructuring a Californian manufacturing facility at a cost of 56 jobs weeks after the announced closure of a plant in North Carolina.
Ingredients: Featured news
John Giannone - incoming IPEC-Americas chairman
Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...
in-Pharmatechnologist.com presents a roundup of news in the fine chemicals sector, beginning with Johnson Matthey which has started a review of its active pharmaceutical ingredient (API) business after competition in the UK impacted its third quarter margins.